History Rhymes with the Psychedelic Boom
As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom.
Pharmaceuticals
-
Read more: History Rhymes with the Psychedelic Boom -
Read more: The Psychedelics Industry: Psychedelic Evangelism in Second Wave Research The Psychedelics Industry: Psychedelic Evangelism in Second Wave Research
Without committing to open science practices, we risk producing a psychedelics industry with the same efficacy and integrity as the self-help industry.
-
Read more: Psychedelics in the Clinical Setting: The Potential for Harm and the Promise of Healing Psychedelics in the Clinical Setting: The Potential for Harm and the Promise of Healing
There are a number of unique issues that psychedelics present in a clinical setting that are yet to be adequately addressed.
-
Read more: Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.
-
Read more: AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit
A rundown of the major legal questions at play in the New York Times-OpenAI lawsuit.
-
Read more: Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies
This concluding post attempts to synthesize contributions to the symposium “From Principles to Practice: Human Rights and Public Health Emergencies”
-
Read more: Climate Change and Neglected Tropical Diseases: Key Takeaways from the WHO-WIPO-WTO Trilateral Symposium Climate Change and Neglected Tropical Diseases: Key Takeaways from the WHO-WIPO-WTO Trilateral Symposium
Neglected tropical diseases were at the forefront of a recent convening on human health and climate change.
-
Read more: The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
Scholars, analysts, and companies cannot agree on what Amgen v. Sanofi means for patients, drug makers, and innovation.
-
Read more: Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling
SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.
-
Read more: Public Health Emergencies and Human Rights Principles: A Solidarity Approach Public Health Emergencies and Human Rights Principles: A Solidarity Approach
The Principles set forth a human rights-based solidarity approach to limit the harmful effects of serious health crises.
